Rosenblatt Marvell · MRVL

Rosenblatt Reaffirms Buy on Marvell, $300 Price Target

Analyst: Sajal Dogra 1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$300
Unchanged
Upside
+90%
MRVL at $158 today
Rosenblatt and Marvell logos

What the analyst said

Rosenblatt analyst Sajal Dogra reiterated a Buy rating and $300 price target on Marvell Technology (NASDAQ: MRVL) following the company’s announcement of its acquisition of Lumentum (NASDAQ: LITE) in an all-stock transaction valued at $115 billion in enterprise value.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

MRVL trades at $158. The 24 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $300 target is in line with the median.

Since the note MRVL has moved −19% (from $196). 12-month window: day 2 of 365, closes on November 2, 2027.

Track record

This callOpen: MRVL has not reached $300 yet. This 12-month target is scored on October 30, 2027. Same target as this firm’s October 30, 2026 note, so it is scored there.

Firm track recordRosenblatt: 58% of its 19 targets at least a year old were reached within 12 months (#25 of 26 firms). Accuracy ranking →

Rosenblatt on Marvell

Rosenblatt price targets on Marvell

7 calls from February 3, 2026 to November 2, 2026. The target went from $115 to $300 (+161%). The rating stayed Buy.

Rosenblatt targetMRVL share price
  1. November 2, 2026 This noteKept the $300 targetBuy$300
  2. October 30, 2026Kept the $300 targetBuy$300
  3. October 7, 2026Kept the $300 targetBuy$300
  4. August 25, 2026Target raised from $240 (+25%)Buy$300
  5. May 28, 2026Target raised from $140 (+71%)Buy$240
  6. March 6, 2026Target raised from $115 (+22%)Buy$140
  7. February 3, 2026Earliest call shownBuy$115
Share

Other analysts on Marvell

StoneXBuy Kept rating and price target Nov 3 $375maintained UBSBuy Kept rating and price target Nov 3 $350maintained Wells FargoBuy Cut price target −22%, kept rating Nov 3 $285from $365 RBC CapitalBuy Cut price target −41%, kept rating Nov 3 $250from $425 NeedhamBuy Cut price target −25%, kept rating Nov 3 $300from $400
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.